Laurie Toich, Assistant Editor

Patients with early stage rheumatoid arthritis may benefit from tapering DMARD therapy.

Women who display non-lump breast cancer symptoms are less likely to seek needed care.

Naturally-occurring genetic variants may improve autoimmune disease treatment.

Ginger-derived nanoparticles could be used to prevent chemotherapy toxicity in colon cancer.

Determining the contents of extracellular vesicles may create targeted treatments.

Top news of the day from across the healthcare landscape.

Biosimilars can provide an easily accessible, low cost treatment option for patients with rheumatoid arthritis.

The Cherokee Nation has partnered with the CDC and other government agencies to increase awareness about hepatitis C virus.

The costs of generic heart failure medications can vary by hundreds of dollars.

Exposing dendritic cells and introducing them into mice nearly eliminated anaphylactic responses.

The use of lansoprazole increased the risk of ischemic stroke by 94%.

Individuals diagnosed with multiple sclerosis later in life had progressed towards disability quickly.

Clinical trials of ARC-520 have been placed on hold by the FDA.

Treatment with Entresto was associated with a reduction in hospitalization and death up to 24% in patients with heart failure.

Treatment with ustekinumab resulted in high rates of remission among patients with Crohn’s disease.

Sixty percent of patients taking guselkumab saw improvements in PsA disease symptoms.

An initiative that lowered copays for prescription drugs also lowered hospitalizations by 40%

Roberta Diaz Brinton, PhD, was granted $10.3 million to determine why women are more likely to develop Alzheimer’s disease.

Mutations in certain genes may increase drug metabolism or decrease drug sensitivity.

Individuals with hepatitis C virus genotypes 1-3 benefited from treatment with MK-3682B

Women with genetic variants had lower hepatitis C viral levels after childbirth.

Roberta Diaz Brinton, PhD, was granted $10.3 million to determine why women are more likely to develop Alzheimer’s disease.

IL-1 antagonists are traditionally used to treat patients with rheumatoid diseases.

Repatha plus statin therapy can reduce atherosclerosis in patients with coronary artery disease.

A small percentage of controlled medications prescribed were disposed of at drop boxes and take-back events.

DNA in the bacteria may also play a role in antibiotic resistance.

Top news of the day from across the healthcare landscape.

Patients who do not respond to interferon-beta treatment for multiple sclerosis have upregulated levels of certain genes.

Out-of-pocket costs may prevent patients with chronic illnesses from purchasing some Affordable Care Act plans.

The imCORE Network Aims to advance cancer immunotherapy drugs.